Fertility Preservation for Cancer Patients: A Review

被引:40
作者
Ajala, Tosin [1 ]
Rafi, Junaid [1 ]
Larsen-Disney, Peter [2 ,3 ]
Howell, Richard [2 ,3 ]
机构
[1] Basingstoke & North Hampshire NHS Trust, Dept Obstet & Gynaecol, Basingstoke RG24 9NA, Hants, England
[2] Brighton Univ Hosp, Dept Obstet & Gynaecol, Brighton BN2 5BE, E Sussex, England
[3] Sussex Univ Hosp, Dept Obstet & Gynaecol, Brighton BN2 5BE, E Sussex, England
关键词
D O I
10.1155/2010/160386
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Infertility can arise as a consequence of treatment of oncological conditions. The parallel and continued improvement in both the management of oncology and fertility cases in recent times has brought to the fore-front the potential for fertility preservation in patients being treated for cancer. Oncologists must be aware of situations where their treatment will affect fertility in patients who are being treated for cancer and they must also be aware of the pathways available for procedures such as cryopreservation of gametes and/or embryos. Improved cancer care associated with increased cure rates and long termsurvival, coupled with advances in fertility treatment means that it is now imperative that fertility preservation is considered as part of the care offered to these patients. This can only be approached within a multidisciplinary setting. There are obvious challenges that still remain to be resolved, especially in the area of fertility preservation in prepubertal patients. These include ethical issues, such as valid consent and research in the area of tissue retrieval, cryopreservation, and transplantation.
引用
收藏
页数:9
相关论文
共 64 条
[31]  
MARRS RP, 1993, COMMENTS POSSIBLE AS
[32]   Consent and the law: review of the current provisions in the Human Fertilisation and Embryology Act 1990 for the UK Health Ministers - Consultation document and questionnaire [J].
McLean, S .
HUMAN REPRODUCTION UPDATE, 1997, 3 (06) :593-621
[33]   Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy [J].
Meirow, D ;
Levron, J ;
Eldar-Geva, T ;
Hardan, I ;
Fridman, E ;
Zalel, Y ;
Schiff, E ;
Dor, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (03) :318-321
[34]   Ovarian stimulation and borderline ovarian tumors: a case-control study [J].
Mosgaard, BJ ;
Lidegaard, O ;
Kjaer, SK ;
Schou, G ;
Andersen, AN .
FERTILITY AND STERILITY, 1998, 70 (06) :1049-1055
[35]  
Multidisciplinary Working Group convened by the British Fertility Society, 2003, Hum Fertil (Camb), V6, pA1
[36]   AN EPIDEMIOLOGIC CASE-CONTROL STUDY OF OVARIAN-CANCER AND REPRODUCTIVE FACTORS [J].
NASCA, PC ;
GREENWALD, P ;
CHOROST, S ;
RICHART, R ;
CAPUTO, T .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 119 (05) :705-713
[37]  
NHS National Institute for Clinical Excellence, 2004, CLIN GUID LIN 11
[38]   Ovarian function after transplantation of frozen, banked autologous ovarian tissue. [J].
Oktay, K ;
Karlikaya, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1919-1919
[39]   Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation [J].
Oktay, K ;
Buyuk, E ;
Libertella, N ;
Akar, M ;
Rosenwaks, Z .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4347-4353
[40]   Ovarian transplantation in humans: indications, techniques and the risk of reseeding cancer [J].
Oktay, K ;
Buyuk, E .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 113 :S45-S47